It is typically taken up to three times a day with meals containing fat
Start at 0.25 mg for four weeks, then increase monthly through 0.5, 1.0, 1.7, and 2.4 mg
Fatigue is most common at two specific points
As metabolic psychiatry moves forward, we need both preclinical and larger, well-controlled clinical studies examining the pleiomorphic effects of ketone bodies in the brain and in the body to understand how we can best leverage whole foods to optimize brain energy, enhance genetic expression, reduce neuroinflammation, optimize metabolic health, and safeguard the promise of our future
PRISMA 2020 Checklist Figure & Data References Citations Citations to this article as recorded by The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis Karolina Hoffmann, Micha Michalak, Manfredi Rizzo, Viviana Maggio, Anna Paczkowska Expert Opinion on Drug Safety.2026